AAPG - CIK 0002023311
The table below shows ASCENTAGE PHARMA GROUP INTERNATIONAL's income statement line items across its last 1 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2024 |
|---|---|
| Revenue | - |
| Cost of revenue | - |
| Gross profit | $130.36M |
| R&D | $129.77M |
| SG&A | - |
| Operating income | - |
| Income tax | - |
| Net income | - |
| EPS (diluted) | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.